Lydon Nicholas - Insider Non-Derivative Transactions at Blueprint Medicines Corp (BPMC) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 12, 2024, Lydon Nicholas's relationship to Blueprint Medicines Corp (BPMC) is Director, and currently has 58,026 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other BPMC insiders.
Data Source: SEC.
Lydon Nicholas - Insider Non-Derivative Transactions of BPMC Common Stock
Lydon Nicholas - Insider Non-Derivative Transactions at BPMC
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 13, 2024 | Acquisition -- (Common Stock) | 2242 | 0 | 58026 |
| Jun 22, 2023 | Acquisition -- (Common Stock) | 2600 | 0 | 55784 |